Ensign Group Inc/TheENSG
ASignal's systematic analysis rates ENSG as Neutral.
Reflects the latest available analysis · analyzed Aug 24, 2026
The case on ENSG
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Revenue growth of 17.3% YoY indicates strong top-line expansion
- Free cash flow of $280.64M supports capital flexibility
- Return on equity of 16.97% reflects solid capital efficiency
- Debt-to-equity ratio of 0.92x is within moderate range
- Dividend yield of 14.00% presents attractive income profile
- Negative MACD histogram (-0.70) suggests weakening momentum
- Price trading below 20-day and 50-day SMAs indicates short-term downtrend
- RSI near neutral at 59.17, lacking strong bullish momentum
- Gross margin of 16.57% is relatively low for healthcare sector
- No Reddit mentions indicate lack of retail investor interest
See the full verdict on ENSG
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes ENSG
Most investors never get a second opinion, let alone several. ASignal runs ENSG past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.